Product Pathways - NF-kappaB Signaling
IkappaB-alpha Antibody #9242
| Applications | Reactivity | Sensitivity | MW (kDa) | Source |
|---|---|---|---|---|
| W IP IHC-P | H M R Mk B Dg (Pg) | Endogenous | 39 | Rabbit |
Applications Key:
W=Western Blotting
IP=Immunoprecipitation
IHC-P=Immunohistochemistry (Paraffin)
Reactivity Key:
H=Human
M=Mouse
R=Rat
Mk=Monkey
Pg=Pig
B=Bovine
Dg=Dog
Species cross-reactivity is determined by Western blot.
Specificity / Sensitivity
IkappaB-alpha Antibody detects endogenous levels of total IkappaB-alpha protein.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with a synthetic peptide (KLH-coupled) derived from the sequence of human IkappaB-alpha. Antibodies are purified by protein A and peptide affinity chromatography.
Western Blotting
Western blot analysis of extracts from HeLa cells treated with TNF-alpha (#2169, 20 ng/ml) for the indicated times, using IkappaB-alpha Antibody.
IHC-P (paraffin)
Immunohistochemical analysis of paraffin-embedded human breast carcinoma, showing cytoplasmic localization, using IkappaB-alpha Antibody.
IHC-P (paraffin)
Immunohistochemical analysis of paraffin-embedded human colon carcinoma, using IkappaB-alpha Antibody.
Background
The NF-κB/Rel transcription factors are present in the cytosol in an inactive state complexed with the inhibitory IκB proteins (1-3). Activation occurs via phosphorylation of IκB-α at Ser32 and Ser36 followed by proteasome-mediated degradation that results in the release and nuclear translocation of active NF-κB (3-7). IκB-α phosphorylation and resulting Rel-dependent transcription are activated by a highly diverse group of extracellular signals including inflammatory cytokines, growth factors and chemokines. Kinases that phosphorylate IκB at these activating sites have been identified (8).
- Baeuerle, P.A. and Baltimore, D. (1988) Science 242, 540-6.
- Beg, A.A. and Baldwin, A.S. (1993) Genes Dev 7, 2064-70.
- Finco, T.S. et al. (1994) Proc Natl Acad Sci USA 91, 11884-8.
- Brown, K. et al. (1995) Science 267, 1485-8.
- Brockman, J.A. et al. (1995) Mol Cell Biol 15, 2809-18.
- Traenckner, E.B. et al. (1995) EMBO J 14, 2876-83.
- Chen, Z.J. et al. (1996) Cell 84, 853-62.
- Karin, M. and Ben-Neriah, Y. (2000) Annu Rev Immunol 18, 621-63.
Application References
- Bonnard, M. et al. (2000) Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J. 19, 4976-4985. This article references the use of IkappaB-alpha Antibody in the following applications: Western Blotting
- Burns, K. et al. (2000) Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat. Cell Biol. 2, 346-351. This article references the use of IkappaB-alpha Antibody in the following applications: Western Blotting
- Delehedde, M. et al. (2000) Fibroblast growth factor-2 stimulation of p42/44MAPK phosphorylation and ikappa B degradation is regulated by heparan sulfate/heparin in rat mammary fibroblasts. J. Biol. Chem. 275, 33905-33910. This article references the use of IkappaB-alpha Antibody in the following applications: Western Blotting
- Hoeflich, K. P. et al. (2000) Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406, 86-90. This article references the use of IkappaB-alpha Antibody in the following applications: Western Blotting
- Todd, D. E. et al. (2004) ERK1/2 and p38 cooperate to induce a p21CIP1-dependent G1 cell cycle arrest. Oncogene 23, 3284-3295. This article references the use of IkappaB-alpha Antibody in the following applications: Western Blotting
- Casciati, A. et al. (2002) Oxidative modulation of nuclear factor-kappaB in human cells expressing mutant fALS-typical superoxide dismutases. J Neurochem 83, 1019-1029. This article references the use of IkappaB-alpha Antibody in the following applications: Western Blotting
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
Companion Products
- 2859 Phospho-IκBα (Ser32) (14D4) Rabbit mAb
- 9246 Phospho-IκBα (Ser32/36) (5A5) Mouse mAb
- 4812 IκBα (44D4) Rabbit mAb
- 4814 IκB-α (L35A5) Mouse mAb (Amino-terminal Antigen)
- 9247 IkappaB-alpha (112B2) Mouse mAb (Carboxy-terminal Antigen)
- 9248 IκB-β Antibody
- 4921 Phospho-IκB-β (Thr19/Ser23) Antibody (Human Specific)
- 9245 Phospho-IκB-β (Ser19/23) Antibody (Mouse/Rat Specific)
- 9249 IκB-ε Antibody
- 4924 Phospho-IκB-ε (Ser18/22) Antibody
- 4764 NF-κB p65 (C22B4) Rabbit mAb
- 3033 Phospho-NF-κB p65 (Ser536) (93H1) Rabbit mAb
- 9243 NF-κB Control Cell Extracts
- 9936 NF-κB Pathway Sampler Kit
- 8112 SignalStain® Antibody Diluent
- 7071 Phototope®-HRP Western Blot Detection System, Anti-rabbit IgG, HRP-linked Antibody
- 7074 Anti-rabbit IgG, HRP-linked Antibody
- 7720 Prestained Protein Marker, Broad Range (Premixed Format)
- 7727 Biotinylated Protein Ladder Detection Pack
- 7003 20X LumiGLO® Reagent and 20X Peroxide
This product is for in vitro research use only and is not intended for use in humans or animals. This product is not intended for use as therapeutic or in diagnostic procedures.